Cargando…
The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells
BACKGROUND/PURPOSE: Acyclic retinoid (ACR) is a promising chemopreventive agent for hepatocellular carcinoma (HCC) that selectively inhibits the growth of HCC cells (JHH7) but not normal hepatic cells (Hc). To better understand the molecular basis of the selective anti-cancer effect of ACR, we perfo...
Autores principales: | Qin, Xian-Yang, Wei, Feifei, Tanokura, Masaru, Ishibashi, Naoto, Shimizu, Masahito, Moriwaki, Hisataka, Kojima, Soichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871542/ https://www.ncbi.nlm.nih.gov/pubmed/24376596 http://dx.doi.org/10.1371/journal.pone.0082860 |
Ejemplares similares
-
Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells
por: Tatsukawa, Hideki, et al.
Publicado: (2011) -
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012) -
Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2018) -
Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013) -
Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
por: Shimizu, Masahito, et al.
Publicado: (2008)